HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Silvio Danese Selected Research

Inflammatory Bowel Diseases (Inflammatory Bowel Disease)

12/2015Integrins and adhesion molecules as targets to treat inflammatory bowel disease.
3/2015European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases.
1/2015New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease.
1/2015Progress with anti-tumor necrosis factor therapeutics for the treatment of inflammatory bowel disease.
1/2015The scientific and regulatory rationale for indication extrapolation: a case study based on the infliximab biosimilar CT-P13.
11/2014Viewpoint: knowledge and viewpoints on biosimilar monoclonal antibodies among members of the European Crohn's and Colitis Organization.
10/2014Intestinal myofibroblast-specific Tpl2-Cox-2-PGE2 pathway links innate sensing to epithelial homeostasis.
9/2014Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?
9/2014VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease.
2/2014Dose optimization is effective in ulcerative colitis patients losing response to infliximab: a collaborative multicentre retrospective study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Silvio Danese Research Topics

Disease

45Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2015 - 01/2003
34Crohn Disease (Crohn's Disease)
12/2015 - 04/2005
32Ulcerative Colitis
12/2015 - 04/2005
30Inflammation
04/2015 - 01/2004
12Colitis
07/2015 - 06/2007
10Neoplasms (Cancer)
11/2015 - 01/2006
6Necrosis
02/2014 - 06/2009
4Fistula
01/2015 - 06/2009
3Colorectal Neoplasms (Colorectal Cancer)
06/2015 - 10/2012
3Autoimmune Diseases (Autoimmune Disease)
01/2014 - 12/2005
2Infection
02/2014 - 01/2011
2Asthma (Bronchial Asthma)
11/2013 - 02/2010
2Pathologic Constriction (Stenosis)
11/2013 - 09/2012
2Thrombosis (Thrombus)
09/2013 - 01/2005
2Celiac Disease (Celiac Sprue)
03/2011 - 01/2005
2Atherosclerosis
02/2010 - 01/2005
1Neoplasm Metastasis (Metastasis)
06/2015
1Pathologic Processes
04/2015
1Wilms Tumor (Wilm's Tumor)
01/2015
1Proteinuria
01/2015
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2015
1Hyperammonemia
01/2015
1Melanoma (Melanoma, Malignant)
06/2014
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2014
1Anemia
01/2014
1Chronic Disease (Chronic Diseases)
01/2014
1Dermatitis
01/2014
1Venous Thrombosis (Deep-Vein Thrombosis)
09/2013
1Tuberculosis (Tuberculoses)
06/2013
1Abscess
09/2012
1Pneumonia (Pneumonitis)
06/2012
1Postoperative Pain
01/2012

Drug/Important Bio-Agent (IBA)

19infliximab (Remicade)FDA Link
07/2015 - 02/2006
13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2015 - 04/2005
10adalimumab (Humira)FDA Link
07/2015 - 06/2009
8CytokinesIBA
01/2015 - 01/2007
5Adrenal Cortex Hormones (Corticosteroids)IBA
12/2015 - 01/2008
5Monoclonal AntibodiesIBA
11/2014 - 01/2007
5AntigensIBA
07/2011 - 01/2004
5Dextrans (Dextran)FDA Link
04/2011 - 06/2007
5CD40 Ligand (CD40L)IBA
03/2011 - 01/2004
4vedolizumabIBA
12/2015 - 08/2013
4Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/2015 - 06/2014
4Budesonide (Pulmicort)FDA LinkGeneric
09/2015 - 01/2008
4IronIBA
03/2015 - 12/2013
4Azathioprine (Imuran)FDA LinkGeneric
08/2014 - 09/2010
4AntibodiesIBA
09/2013 - 01/2005
4Protein CIBA
12/2011 - 07/2007
4sodium sulfate (sodium bisulfate)FDA LinkGeneric
04/2011 - 07/2008
3Proteins (Proteins, Gene)IBA
04/2010 - 07/2006
3CDP870FDA Link
02/2010 - 02/2008
2IntegrinsIBA
12/2015 - 11/2014
2Urokinase Plasminogen Activator ReceptorsIBA
11/2015 - 04/2015
2Dextran SulfateIBA
07/2015 - 02/2009
2Vascular Endothelial Growth Factor CIBA
06/2015 - 09/2014
2Transcription Factors (Transcription Factor)IBA
01/2015 - 03/2011
2Interleukin-12 (IL 12)IBA
01/2015 - 01/2010
2Immunoglobulins (Immunoglobulin)IBA
11/2014 - 04/2010
2Immunosuppressive Agents (Immunosuppressants)IBA
07/2014 - 10/2010
2golimumabFDA Link
02/2014 - 09/2013
2Prothrombin (Factor II)IBA
09/2013 - 06/2003
2Immunologic Factors (Immunomodulators)IBA
06/2012 - 02/2010
2Chemokine CX3CL1IBA
03/2011 - 01/2007
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
03/2011 - 04/2005
2Beclomethasone (Beclometasone)FDA Link
12/2008 - 01/2008
1Plasminogen Activators (Plasminogen Activator)IBA
04/2015
1nephrinIBA
01/2015
1Free RadicalsIBA
01/2015
1Janus KinasesIBA
01/2015
1Phosphotransferases (Kinase)IBA
10/2014
1Dinoprostone (PGE2)FDA Link
10/2014
1erucylphosphocholineIBA
06/2014
1Hyaluronic Acid (Hyaluronan)IBA
04/2014
1Interleukin-6 (Interleukin 6)IBA
11/2013
1Interleukin-13IBA
11/2013
16-Mercaptopurine (Mercaptopurine)FDA LinkGeneric
11/2013
1Methotrexate (Mexate)FDA LinkGeneric
11/2013
1APTIBA
09/2013
1SteroidsIBA
06/2013
1Dihydrotachysterol (AT 10)IBA
06/2013
1Calcibiotic Root Canal SealerIBA
10/2012
1BariumIBA
09/2012
1MicroRNAs (MicroRNA)IBA
03/2012
1Anti-Bacterial Agents (Antibiotics)IBA
03/2012
1rifaximin (L 105)FDA Link
03/2012
1CosmeticsIBA
01/2012

Therapy/Procedure

4Biological Therapy
09/2011 - 07/2006
3Remission Induction
09/2015 - 12/2008
2Therapeutics
01/2015 - 01/2011
2Enema (Enemas)
04/2014 - 01/2008
2Drug Therapy (Chemotherapy)
01/2012 - 01/2010
1Stem Cell Transplantation
12/2015
1Hematopoietic Stem Cell Transplantation
12/2015
1Intraperitoneal Injections
07/2015
1Injections
06/2015
1Combined Modality Therapy
01/2015
1Complementary Therapies (Alternative Medicine)
09/2014
1Tissue Therapy (Cell Therapy)
06/2014
1Colectomy
02/2014
1Chemoprevention
01/2014